Clinical Trials
5
Active:3
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Cytavis Biopharma GmbH
- Target Recruit Count
- 77
- Registration Number
- NCT00932724
- Locations
- 🇦🇹
Bezirkskrankenhaus Hall, Hall in Tirol, Austria
🇦🇹Medizinische Universität Innsbruck, Innsbruck, Austria
🇦🇹Bezirkskrankenhaus Kufstein, Kufstein, Austria
CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
Phase 2
Completed
- Conditions
- Melanoma
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Cytavis Biopharma GmbH
- Target Recruit Count
- 31
- Registration Number
- NCT00658437
- Locations
- 🇩🇪
Haut Tumor Zentrum Charité, Berlin, Germany
🇩🇪Dermatologisches Zentrum Elbe-Klinikum Buxtehude, Buxtehude, Germany
🇩🇪Hautklinik Linden MH Hannover, Hannover, Germany
News
No news found